Australia markets closed
  • ALL ORDS

    7,249.70
    +27.20 (+0.38%)
     
  • ASX 200

    7,048.60
    +23.80 (+0.34%)
     
  • AUD/USD

    0.6437
    +0.0006 (+0.09%)
     
  • OIL

    90.77
    -0.94 (-1.02%)
     
  • GOLD

    1,864.60
    -14.00 (-0.75%)
     
  • Bitcoin AUD

    42,096.83
    +171.20 (+0.41%)
     
  • CMC Crypto 200

    579.66
    +0.90 (+0.15%)
     
  • AUD/EUR

    0.6085
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.0725
    -0.0051 (-0.48%)
     
  • NZX 50

    11,296.43
    +118.40 (+1.06%)
     
  • NASDAQ

    14,715.24
    +12.48 (+0.08%)
     
  • FTSE

    7,608.08
    +6.23 (+0.08%)
     
  • Dow Jones

    33,507.50
    -158.84 (-0.47%)
     
  • DAX

    15,386.58
    +63.08 (+0.41%)
     
  • Hang Seng

    17,809.66
    +436.63 (+2.51%)
     
  • NIKKEI 225

    31,857.62
    -14.90 (-0.05%)
     

Looking for Steady, Passive Income? Buy AbbVie Stock

Looking for Steady, Passive Income? Buy AbbVie Stock

Dividend growth investing revolves around selecting only the most reliable businesses for your portfolio. This can be measured by consecutive years of dividend growth. With 51 consecutive years of dividend growth to its credit (including time spent as part of Abbott Laboratories), AbbVie (NYSE: ABBV) certainly has such a record.